Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
International Journal of Cardiology. Heart & Vasculature
|
May 22, 2019
Comparative effectiveness of rivaroxaban versus a vitamin K antagonist in patients with renal impairment treated for non-valvular atrial fibrillation in Germany - A retrospective cohort study
Hendrik Bonnemeier, Maria Huelsebeck, Sebastian Kloss
Pharmaceutical Statistics
|
June 14, 2016
Safety data from randomized controlled trials: applying models for recurrent events
Johannes Hengelbrock, Johanna Gillhaus, Sebastian Kloss, et al.
Pharmacoepidemiology and Drug Safety
|
February 26, 2011
Linkage of mother-baby pairs in the German Pharmacoepidemiological Research Database
Edeltraut Garbe, Marc Suling, Sebastian Kloss, et al.
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen
|
November 28, 2018
[Estimating the incidence of venous thromboembolism (VTE) using various types of routine data of the German healthcare system]
Christoph Ohlmeier, Friedhelm Leverkus, Sebastian Kloss, et al.
International Journal of Cardiology
|
March 4, 2024
Comparative effectiveness of factor Xa non-vitamin K antagonist oral anticoagulants versus phenprocoumon in patients with non-valvular atrial fibrillation
Reinhold Kreutz, Sebastian Kloss, Dirk Enders, et al.
BMJ Open
|
September 29, 2016
Early real-world evidence of persistence on oral anticoagulants for stroke prevention in non-valvular atrial fibrillation: a cohort study in UK primary care
Michelle E Johnson, Cinira Lefèvre, Shuk-Li Collings, et al.
Pharmacoepidemiology and Drug Safety
|
November 9, 2022
High-dimensional propensity scores for empirical covariate selection in secondary database studies: Planning, implementation, and reporting
Jeremy A Rassen, Patrick Blin, Sebastian Kloss, et al.
GMS Infectious Diseases
|
January 24, 2019
Treatment of MRSA pneumonia: Clinical and economic comparison of linezolid vs. vancomycin - a retrospective analysis of medical charts and re-imbursement data of real-life patient populations
Michael H Wilke, Karsten Becker, Sebastian Kloss, et al.
Drug Discovery Today
|
January 17, 2018
The positive impacts of Real-World Data on the challenges facing the evolution of biopharma
John Wise, Angeli Möller, David Christie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 14, 2025
Real-World Outcomes of Elacestrant in ER+, HER2-, ESR1-Mutant Metastatic Breast Cancer
Hope S Rugo, Virginia Kaklamani, Heather McArthur, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
International Journal of Cardiology. Heart & Vasculature
|
May 22, 2019
Comparative effectiveness of rivaroxaban versus a vitamin K antagonist in patients with renal impairment treated for non-valvular atrial fibrillation in Germany - A retrospective cohort study
Hendrik Bonnemeier, Maria Huelsebeck, Sebastian Kloss
Pharmaceutical Statistics
|
June 14, 2016
Safety data from randomized controlled trials: applying models for recurrent events
Johannes Hengelbrock, Johanna Gillhaus, Sebastian Kloss, et al.
Pharmacoepidemiology and Drug Safety
|
February 26, 2011
Linkage of mother-baby pairs in the German Pharmacoepidemiological Research Database
Edeltraut Garbe, Marc Suling, Sebastian Kloss, et al.
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen
|
November 28, 2018
[Estimating the incidence of venous thromboembolism (VTE) using various types of routine data of the German healthcare system]
Christoph Ohlmeier, Friedhelm Leverkus, Sebastian Kloss, et al.
International Journal of Cardiology
|
March 4, 2024
Comparative effectiveness of factor Xa non-vitamin K antagonist oral anticoagulants versus phenprocoumon in patients with non-valvular atrial fibrillation
Reinhold Kreutz, Sebastian Kloss, Dirk Enders, et al.
BMJ Open
|
September 29, 2016
Early real-world evidence of persistence on oral anticoagulants for stroke prevention in non-valvular atrial fibrillation: a cohort study in UK primary care
Michelle E Johnson, Cinira Lefèvre, Shuk-Li Collings, et al.
Pharmacoepidemiology and Drug Safety
|
November 9, 2022
High-dimensional propensity scores for empirical covariate selection in secondary database studies: Planning, implementation, and reporting
Jeremy A Rassen, Patrick Blin, Sebastian Kloss, et al.
GMS Infectious Diseases
|
January 24, 2019
Treatment of MRSA pneumonia: Clinical and economic comparison of linezolid vs. vancomycin - a retrospective analysis of medical charts and re-imbursement data of real-life patient populations
Michael H Wilke, Karsten Becker, Sebastian Kloss, et al.
Drug Discovery Today
|
January 17, 2018
The positive impacts of Real-World Data on the challenges facing the evolution of biopharma
John Wise, Angeli Möller, David Christie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 14, 2025
Real-World Outcomes of Elacestrant in ER+, HER2-, ESR1-Mutant Metastatic Breast Cancer
Hope S Rugo, Virginia Kaklamani, Heather McArthur, et al.
Page
of 2